Warren Buffett Royalty Pharma PLC Transaction History

Berkshire Hathaway Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$37.53 - $44.22 $56.2 Million - $66.2 Million	-1,496,372 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$37.46 - $42.44 $268 Million - $304 Million	-7,151,896 Reduced 82.7%	1,496,372 $58.3 Million
Q4 2021 Feb 14, 2022	SELL	$35.17 - $42.48 $158 Million - $191 Million	-4,497,634 Reduced 34.21%	8,648,268 $345 Million
Q3 2021 Nov 15, 2021	BUY	$36.14 - $42.24 $475 Million - $555 Million	13,145,902 New	13,145,902 $475 Million

522

285M

1.67M

384K

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $17.4B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

Get notified when there are updates to the investment portfolio of Berkshire Hathaway Inc, based on Form 13F filings with the SEC.

Stay updated on Berkshire Hathaway Inc and Warren Buffett with notifications on news.